<SEC-DOCUMENT>0001140361-20-012850.txt : 20200601
<SEC-HEADER>0001140361-20-012850.hdr.sgml : 20200601
<ACCEPTANCE-DATETIME>20200601171348
ACCESSION NUMBER:		0001140361-20-012850
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20200601
DATE AS OF CHANGE:		20200601
EFFECTIVENESS DATE:		20200601

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SIGA TECHNOLOGIES INC
		CENTRAL INDEX KEY:			0001010086
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				133864870
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38436
		FILM NUMBER:		20934342

	BUSINESS ADDRESS:	
		STREET 1:		31 EAST 62ND STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10065
		BUSINESS PHONE:		212-672-9100

	MAIL ADDRESS:	
		STREET 1:		31 EAST 62ND STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10065

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SIGA PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19961108
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>formdefa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit, a Broadridge Company
         Document created using EDGARfilings PROfile 7.0.0.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
  <div>
    <div style="text-align: center; font-size: 14pt; font-weight: bold;">UNITED STATES</div>
    <div style="text-align: center; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>
    <div><br>
    </div>
    <div style="text-align: center; font-size: 18pt; font-weight: bold;">SCHEDULE 14A</div>
    <div>&#160;</div>
    <div style="text-align: center;">Proxy Statement Pursuant to Section 14(a) of</div>
    <div style="text-align: center;">the Securities Exchange Act of 1934</div>
    <div>&#160;</div>
    <div>Filed by the Registrant &#9746;</div>
    <div>Filed by a Party other than the Registrant &#9744;</div>
    <div>Check the appropriate box:</div>
    <div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z239e4cc70c3c4b79a84df90947bd2bb3" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 45pt;">
              <div style="text-align: left;">&#9744;</div>
            </td>
            <td style="vertical-align: top; width: auto;">
              <div style="text-align: left;">Preliminary Proxy Statement</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z85f7c9293eda4ec6b83389c31611250c" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 45pt;">
              <div style="text-align: left;">&#9744;</div>
            </td>
            <td style="vertical-align: top; width: auto;">
              <div style="text-align: left;"><font style="font-weight: bold;">Confidential, for Use of the Commission Only (as permitted by Rule 14a&#8209;6(e)(2))</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zeaf46350c2834984b52281cd27ba2ea0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 45pt;">
              <div style="text-align: left;">&#9744;</div>
            </td>
            <td style="vertical-align: top; width: auto;">
              <div style="text-align: left;">Definitive Proxy Statement</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zb5bab92f18fe411fb50c99586f3cd276" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 45pt;">
              <div style="text-align: left;">&#9746;</div>
            </td>
            <td style="vertical-align: top; width: auto;">
              <div style="text-align: left;">Definitive Additional Materials</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z56c85bb7995040129e549ccfd2c05dc2" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 45pt;">
              <div style="text-align: left;">&#9744;</div>
            </td>
            <td style="vertical-align: top; width: auto;">
              <div style="text-align: left;">Soliciting Material under Rule 14a&#8209;12</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-size: 24pt; font-weight: bold;">SIGA TECHNOLOGIES, INC.</div>
    <div><br>
    </div>
    <div style="text-align: center;">(Name of Registrant as Specified In Its Charter)</div>
    <div><br>
    </div>
    <div style="text-align: center;">(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</div>
    <div><br>
    </div>
    <div>Payment of Filing Fee (Check the appropriate box):</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z7928f3c33f5a44559bc17f864cedbd15">

        <tr>
          <td style="width: 6%; vertical-align: top;">&#9746;</td>
          <td colspan="2" style="vertical-align: bottom;">
            <div>No fee required.</div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 6%; vertical-align: top;">&#160;</td>
          <td rowspan="1" colspan="2" style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 6%; vertical-align: bottom;">&#9744;</td>
          <td colspan="2" style="vertical-align: bottom;">
            <div>Fee computed on table below per Exchange Act Rules 14a&#8209;6(i)(1) and 0-11.</div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 6%; vertical-align: bottom;">&#160;</td>
          <td rowspan="1" colspan="2" style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 6%; vertical-align: bottom;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">
            <div>(1)</div>
          </td>
          <td style="width: 91%; vertical-align: top;">
            <div>
              <div>Title of each class of securities to which transaction applies:</div>
            </div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 6%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td rowspan="1" style="width: 3%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td rowspan="1" style="width: 91%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>
        <tr>
          <td style="width: 6%; vertical-align: bottom;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">
            <div>(2)</div>
          </td>
          <td style="width: 91%; vertical-align: top;">
            <div>
              <div>Aggregate number of securities to which transaction applies:</div>
            </div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 6%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td rowspan="1" style="width: 3%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td rowspan="1" style="width: 91%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>
        <tr>
          <td style="width: 6%; vertical-align: bottom;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">
            <div>(3)</div>
          </td>
          <td style="width: 91%; vertical-align: top;">
            <div>
              <div>Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0&#8209;11 (set forth the amount on which the filing fee is calculated and state how it was determined):</div>
            </div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 6%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td rowspan="1" style="width: 3%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td rowspan="1" style="width: 91%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>
        <tr>
          <td style="width: 6%; vertical-align: bottom;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">
            <div>(4)</div>
          </td>
          <td style="width: 91%; vertical-align: top;">
            <div>
              <div>Proposed maximum aggregate value of transaction:</div>
            </div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 6%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td rowspan="1" style="width: 3%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td rowspan="1" style="width: 91%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>
        <tr>
          <td style="width: 6%; vertical-align: bottom;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">
            <div>(5)</div>
          </td>
          <td style="width: 91%; vertical-align: top;">
            <div>
              <div>Total fee paid:</div>
            </div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 6%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td rowspan="1" style="width: 3%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td rowspan="1" style="width: 91%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 6%; vertical-align: bottom;">&#160;</td>
          <td rowspan="1" colspan="2" style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 6%; vertical-align: bottom;">&#9744;</td>
          <td colspan="2" style="vertical-align: bottom;">
            <div>Fee paid previously with preliminary materials.</div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 6%; vertical-align: bottom;">&#160;</td>
          <td rowspan="1" colspan="2" style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 6%; vertical-align: top;">&#9744;</td>
          <td colspan="2" style="vertical-align: bottom;">
            <div>Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or
              Schedule and the date of its filing.</div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 6%; vertical-align: top;">&#160;</td>
          <td rowspan="1" colspan="2" style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 6%; vertical-align: bottom;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">
            <div>(1)</div>
          </td>
          <td style="width: 91%; vertical-align: top;">
            <div>
              <div>Amount Previously Paid:</div>
            </div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 6%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td rowspan="1" style="width: 3%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td rowspan="1" style="width: 91%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>
        <tr>
          <td style="width: 6%; vertical-align: bottom;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">
            <div>(2)</div>
          </td>
          <td style="width: 91%; vertical-align: top;">
            <div>
              <div>Form, Schedule or Registration Statement No.:</div>
            </div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 6%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td rowspan="1" style="width: 3%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td rowspan="1" style="width: 91%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>
        <tr>
          <td style="width: 6%; vertical-align: bottom;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">
            <div>(3)</div>
          </td>
          <td style="width: 91%; vertical-align: top;">
            <div>
              <div>Filing Party:</div>
            </div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 6%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td rowspan="1" style="width: 3%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td rowspan="1" style="width: 91%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>
        <tr>
          <td style="width: 6%; vertical-align: bottom;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">
            <div>(4)</div>
          </td>
          <td style="width: 91%; vertical-align: top;">
            <div>
              <div>Date Filed:</div>
            </div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 6%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td rowspan="1" style="width: 3%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td rowspan="1" style="width: 91%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div>
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; color: #000000;">
      <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 12%; color: #000000;"></div>
    <div style="text-align: center; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; font-weight: bold;">SIGA Technologies, Inc.</div>
    <div style="text-align: center;">31 East 62nd Street</div>
    <div style="text-align: center;">New York, New York 10065</div>
    <div style="text-align: center;">(212) 672-9100</div>
    <div style="text-align: center;"> <br>
    </div>
    <div style="text-align: center; color: #000000;">
      <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 12%; color: #000000;"></div>
    <br>
    <div style="text-align: center; color: #000000; font-weight: bold;">ADDITIONAL INFORMATION REGARDING THE 2020 ANNUAL MEETING OF STOCKHOLDERS</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">TO BE HELD ON TUESDAY, JUNE 16, 2020</div>
    <div style="text-align: center; color: #000000; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; color: #000000;">
      <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 12%; color: #000000;"></div>
    <div style="color: #000000;"> <br>
    </div>
    <div style="color: #000000;">The following Notice of Change of Location (the &#8220;Notice&#8221;) supplements and relates to the proxy statement (the &#8220;Proxy Statement&#8221;) of SIGA Technologies, Inc. (the &#8220;Company&#8221;), dated April 28, 2020, furnished to stockholders of
      the Company in connection with the solicitation of proxies by the Board of Directors of the Company for use at the 2020 Annual Meeting of Stockholders to be held on Tuesday, June 16, 2020. This Notice is being filed with the Securities and Exchange
      Commission and is being made available to stockholders on or about June 1, 2020.</div>
    <div style="color: #000000;"> <br>
    </div>
    <div style="text-align: center; color: #000000;">
      <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 12%; color: #000000;"></div>
    <div style="text-align: center; color: #000000; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; color: #000000; font-weight: bold;">THIS NOTICE SHOULD BE READ IN CONJUNCTION WITH THE PROXY STATEMENT AND</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">ORIGINAL NOTICE</div>
    <div style="text-align: center; color: #000000; font-weight: bold;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 12%; color: #000000; text-align: center;"></div>
    <div style="text-align: center; color: #000000; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; color: #000000; font-weight: bold;">NOTICE OF CHANGE OF LOCATION OF</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">ANNUAL MEETING OF STOCKHOLDERS</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">TO BE HELD ON TUESDAY, JUNE 16, 2020</div>
    <div><br>
    </div>
    <div style="background-color: rgb(255, 255, 255);">
      <div style="text-align: center; color: rgb(68, 68, 68); font-weight: bold; font-size: 14pt;">SIGA Changes its 2020 Annual Meeting of Stockholders to Virtual Format</div>
    </div>
    <div style="background-color: #FEFEFE;">
      <div><br>
      </div>
      <div>June 1, 2020</div>
      <div><br>
      </div>
    </div>
    <div style="background-color: #FEFEFE;">
      <div style="text-align: justify;">NEW YORK -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it will host its 2020 Annual Meeting of Stockholders
        (the &#8220;Annual Meeting&#8221;) as a virtual-only meeting that will be held via live audio webcast due to the public health and safety concerns related to the COVID-19 pandemic, recommendations and orders from federal, state and local authorities, and to
        support the health and well-being of its stockholders, employees, and others.</div>
      <div>&#160;</div>
      <div style="text-align: justify;">The previously announced date and time of the Annual Meeting, Tuesday, June 16, 2020 at 10:30 a.m. Eastern Daylight Time, as disclosed in the proxy materials previously distributed by the Company, has not changed.
        Stockholders will not be able to attend the Annual Meeting in person.&#160; A notice regarding this change to a virtual meeting format is being filed with the Securities and Exchange Commission together with this press release.</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-weight: bold;">Attending the Meeting; Process for Submitting Questions</div>
      <div>&#160;</div>
    </div>
    <div style="background-color: #FFFFFF;">
      <div style="text-align: justify; font-family: 'Times New Roman',Times,serif;">
        <div style="font-family: 'Times New Roman'; background-color: rgb(254, 254, 254); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">
          <div style="background-color: rgb(254, 254, 254); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">
            <div>
              <div style="font-family: 'Times New Roman',Times,serif;">Stockholders as of the close of business on April 24, 2020 are entitled to attend the Annual Meeting. Stockholders of record wishing to attend the annual meeting may do so by visiting <u>https://web.lumiagm.com/294073489</u>,
                entering the 11-digit control number included on the proxy card, voting instruction form or notice they previously received and entering the password &#8220;siga2020&#8221; (the password is case sensitive).&#160;Stockholders holding their shares through a
                broker, bank or other intermediary as of the close of business on April 24, 2020 and wishing to attend may do so by visiting the same website, by logging in as a guest and providing the additional identifying information requested at such
                time.&#160;All stockholders may log into the meeting platform beginning at 10:15 a.m. Eastern Time on June 16, 2020.&#160;If you have questions regarding access to the annual meeting, please visit <u>https://go.lumiglobal.com/faq</u>.</div>
            </div>
          </div>
        </div>
        <font style="background-color: rgb(254, 254, 254); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"> </font>
        <div><br>
        </div>
      </div>
    </div>
    <div style="background-color: #FEFEFE;">
      <div style="text-align: justify;">Prior to the Annual Meeting, stockholders may submit questions relating to the subject matter of the meeting via email to annualmeetingquestion@siga.com.&#160; All questions from stockholders must be received by 5:00 p.m.
        Eastern Time on Thursday, June 11, 2020.&#160; Questions will be answered depending on the availability of time and members of management participating in the Annual Meeting.</div>
      <div>&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; font-weight: bold;">Voting</div>
      <div>&#160;</div>
      <div style="text-align: justify;">All stockholders, whether or not planning to attend the virtual Annual Meeting, will be required to vote promptly in advance of the meeting by using one of the methods described in the proxy materials for voting
        prior to the Annual Meeting. The proxy card included with the previously distributed proxy materials will not be reissued and may continue to be used to vote shares in connection with the Annual Meeting.&#160; Stockholders who have already voted do not
        need to take any additional action.&#160; Stockholders who have not yet voted are urged to submit their votes promptly, as voting will not be available during the meeting.</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-weight: bold;">ABOUT SIGA TECHNOLOGIES, INC. and TPOXX<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
      <div>&#160;</div>
      <div style="text-align: justify;">SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on the health security market. Health security comprises countermeasures for biological, chemical, radiological and nuclear attacks
        (biodefense market), vaccines and therapies for emerging infectious diseases, and health preparedness. Our lead product is TPOXX<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>, also known as tecovirimat and ST-246<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>, an orally administered and IV formulation antiviral drug
        for the treatment of human smallpox disease caused by variola virus. TPOXX is a novel small-molecule drug and the US maintains a stockpile of TPOXX in the Strategic National Stockpile under Project BioShield. The oral formulation of TPOXX was
        approved by the FDA for the treatment of smallpox in 2018. The full label is here <u>https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208627s000lbl.pdf</u>.&#160; In September 2018, SIGA signed a contract of more than $600 million with the
        Biomedical Advanced Research and Development Authority (BARDA), part of the office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services, for additional procurement and development related
        to both oral and intravenous formulations of TPOXX. For more information about SIGA, please visit www.siga.com.</div>
      <div>&#160;</div>
    </div>
    <div style="background-color: #FEFEFE;">
      <div style="text-align: justify; font-weight: bold;">ABOUT SMALLPOX<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">i</sup></div>
      <div>&#160;</div>
    </div>
    <div style="background-color: #FEFEFE;">
      <div style="text-align: justify;">Smallpox is a contagious, disfiguring and often deadly disease that has affected humans for thousands of years. Naturally-occurring smallpox was eradicated worldwide by 1980, the result of an unprecedented global
        immunization campaign. Samples of smallpox virus have been kept for research purposes. This has led to concerns that smallpox could someday be used as a biological warfare agent. A vaccine can prevent smallpox, but the risk of the current vaccine&#8217;s
        side effects is too high to justify routine vaccination for people at low risk of exposure to the smallpox virus.</div>
      <div>&#160;</div>
      <div>
        <div><br>
        </div>
        <hr noshade="noshade" align="left" style="background-color: #000000; border-bottom: 0px none; border-left: 0px none; border-right: 0px none; border-top: 0px none; margin: 0px auto 0px 0px; height: 2px; width: 25%; color: #000000;">
        <div><u><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">i</sup> http://www.mayoclinic.org/diseases-conditions/smallpox/basics/definition/con-20022769 </u></div>
        <div><br>
        </div>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; font-weight: bold;">FORWARD-LOOKING STATEMENTS</div>
      <div>&#160;</div>
      <div style="text-align: justify;">This press release contains certain &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Such forward-looking statements are subject to various known
        and unknown risks and uncertainties, and SIGA cautions you that any forward-looking information provided by or on behalf of SIGA is not a guarantee of future performance. More detailed information about SIGA and risk factors that may affect the
        realization of forward-looking statements, including the forward-looking statements in this press release, is set forth in SIGA&#8217;s filings with the Securities and Exchange Commission, including SIGA&#8217;s Annual Report on Form 10-K for the fiscal year
        ended December 31, 2019, and in other documents that SIGA has filed with the SEC. SIGA urges investors and security holders to read those documents free of charge at the SEC&#8217;s web site at http://www.sec.gov. Interested parties may also obtain those
        documents free of charge from SIGA. Forward-looking statements are current only as of the date on which such statements were made, and except for our ongoing obligations under the United States of America federal securities laws, we undertake no
        obligation to update publicly any forward-looking statements whether as a result of new information, future events, or otherwise.</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-style: italic;">The information contained in this press release does not necessarily reflect the position or the policy of the Government and no official endorsement should be inferred.</div>
      <div>&#160;</div>
    </div>
    <div style="background-color: #FEFEFE;">
      <div style="font-weight: bold;">Contacts:</div>
      <div>&#160;</div>
    </div>
    <div style="background-color: #FEFEFE;">
      <div><u>Investors</u></div>
      <div>David Carey</div>
      <div>212-867-1768</div>
      <div><u>david.carey@finnpartners.com</u></div>
      <div><br>
      </div>
      <div><u>Media</u></div>
      <div>Stephanie Seiler</div>
      <div>206-713-0124</div>
    </div>
    <div><u>stephanie.seiler@finnpartners.com</u></div>
    <br>
    <div><br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
